126 related articles for article (PubMed ID: 32633087)
1. Dysregulation of CCN3 (NOV) expression in the epidermis of systemic sclerosis patients with pigmentary changes.
Henrot P; Pain C; Taïeb A; Truchetet ME; Cario M
Pigment Cell Melanoma Res; 2020 Nov; 33(6):895-898. PubMed ID: 32633087
[TBL] [Abstract][Full Text] [Related]
2. Decreased CCN3 in Systemic Sclerosis Endothelial Cells Contributes to Impaired Angiogenesis.
Henrot P; Moisan F; Laurent P; Manicki P; Kaulanjan-Checkmodine P; Jolivel V; Rezvani HR; Leroy V; Picard F; Boulon C; Schaeverbeke T; Seneschal J; Lazaro E; Taïeb A; Truchetet ME; Cario M
J Invest Dermatol; 2020 Jul; 140(7):1427-1434.e5. PubMed ID: 31954725
[TBL] [Abstract][Full Text] [Related]
3. Study of CCN3 (NOV) and DDR1 in normal melanocytes and vitiligo skin.
Ricard AS; Pain C; Daubos A; Ezzedine K; Lamrissi-Garcia I; Bibeyran A; Guyonnet-Dupérat V; Taieb A; Cario-André M
Exp Dermatol; 2012 Jun; 21(6):411-6. PubMed ID: 22507556
[TBL] [Abstract][Full Text] [Related]
4. Antagonistic effect of the matricellular signaling protein CCN3 on TGF-beta- and Wnt-mediated fibrillinogenesis in systemic sclerosis and Marfan syndrome.
Lemaire R; Farina G; Bayle J; Dimarzio M; Pendergrass SA; Milano A; Perbal B; Whitfield ML; Lafyatis R
J Invest Dermatol; 2010 Jun; 130(6):1514-23. PubMed ID: 20182440
[TBL] [Abstract][Full Text] [Related]
5. Correlation between diffuse pigmentation and keratinocyte-derived endothelin-1 in systemic sclerosis.
Tabata H; Hara N; Otsuka S; Yamakage A; Yamazaki S; Koibuchi N
Int J Dermatol; 2000 Dec; 39(12):899-902. PubMed ID: 11168657
[TBL] [Abstract][Full Text] [Related]
6. CCN3 controls 3D spatial localization of melanocytes in the human skin through DDR1.
Fukunaga-Kalabis M; Martinez G; Liu ZJ; Kalabis J; Mrass P; Weninger W; Firth SM; Planque N; Perbal B; Herlyn M
J Cell Biol; 2006 Nov; 175(4):563-9. PubMed ID: 17101694
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of CCN3 expression as a potential mechanism for melanoma progression.
Fukunaga-Kalabis M; Martinez G; Telson SM; Liu ZJ; Balint K; Juhasz I; Elder DE; Perbal B; Herlyn M
Oncogene; 2008 Apr; 27(18):2552-60. PubMed ID: 17968313
[TBL] [Abstract][Full Text] [Related]
8. CCN proteins as potential actionable targets in scleroderma.
Henrot P; Truchetet ME; Fisher G; Taïeb A; Cario M
Exp Dermatol; 2019 Jan; 28(1):11-18. PubMed ID: 30329180
[TBL] [Abstract][Full Text] [Related]
9. Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis.
Distler JH; Jüngel A; Kowal-Bielecka O; Michel BA; Gay RE; Sprott H; Matucci-Cerinic M; Chilla M; Reich K; Kalden JR; Müller-Ladner U; Lorenz HM; Gay S; Distler O
Arthritis Rheum; 2005 Mar; 52(3):856-64. PubMed ID: 15751077
[TBL] [Abstract][Full Text] [Related]
10. Increased pigmentation in scleroderma.
Pope JE; Shum DT; Gottschalk R; Stevens A; McManus R
J Rheumatol; 1996 Nov; 23(11):1912-6. PubMed ID: 8923365
[TBL] [Abstract][Full Text] [Related]
11. Melanin Transfer in the Epidermis: The Pursuit of Skin Pigmentation Control Mechanisms.
Moreiras H; Seabra MC; Barral DC
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33923362
[TBL] [Abstract][Full Text] [Related]
12. Reduced immunohistochemical expression of CCN3 in vitiligo.
Faria AR; Jung JE; Silva de Catro CC; de Noronha L
Indian J Dermatol Venereol Leprol; 2018; 84(5):558-562. PubMed ID: 29998862
[TBL] [Abstract][Full Text] [Related]
13. Reduced NOV/CCN3 Expression Limits Inflammation and Interstitial Renal Fibrosis after Obstructive Nephropathy in Mice.
Marchal PO; Kavvadas P; Abed A; Kazazian C; Authier F; Koseki H; Hiraoka S; Boffa JJ; Martinerie C; Chadjichristos CE
PLoS One; 2015; 10(9):e0137876. PubMed ID: 26367310
[TBL] [Abstract][Full Text] [Related]
14. A potential contribution of decreased galectin-7 expression in stratified epithelia to the development of cutaneous and oesophageal manifestations in systemic sclerosis.
Saigusa R; Yamashita T; Miura S; Hirabayashi M; Nakamura K; Miyagawa T; Fukui Y; Yoshizaki A; Sato S; Asano Y
Exp Dermatol; 2019 May; 28(5):536-542. PubMed ID: 30739341
[TBL] [Abstract][Full Text] [Related]
15. NOV/CCN3 induces cartilage protection by inhibiting PI3K/AKT/mTOR pathway.
Huang X; Ni B; Mao Z; Xi Y; Chu X; Zhang R; Ma X; You H
J Cell Mol Med; 2019 Nov; 23(11):7525-7534. PubMed ID: 31454155
[TBL] [Abstract][Full Text] [Related]
16. Pigmentation and melanocyte supply to the epidermis depend on type XVII collagen.
Gostyński A; Pasmooij AM; Del Rio M; Diercks GF; Pas HH; Jonkman MF
Exp Dermatol; 2014 Feb; 23(2):130-2. PubMed ID: 24330315
[TBL] [Abstract][Full Text] [Related]
17. Dysfunctional Keratinocytes Increase Dermal Inflammation in Systemic Sclerosis: Results From Studies Using Tissue-Engineered Scleroderma Epidermis.
Russo B; Borowczyk J; Boehncke WH; Truchetet ME; Modarressi A; Brembilla NC; Chizzolini C
Arthritis Rheumatol; 2021 Jul; 73(7):1311-1317. PubMed ID: 33497035
[TBL] [Abstract][Full Text] [Related]
18. Impact of ultraviolet radiation on dermal and epidermal DNA damage in a human pigmented bilayered skin substitute.
Goyer B; Pereira U; Magne B; Larouche D; Kearns-Turcotte S; Rochette PJ; Martin L; Germain L
J Tissue Eng Regen Med; 2019 Dec; 13(12):2300-2311. PubMed ID: 31502756
[TBL] [Abstract][Full Text] [Related]
19. Epithelial cells promote fibroblast activation via IL-1alpha in systemic sclerosis.
Aden N; Nuttall A; Shiwen X; de Winter P; Leask A; Black CM; Denton CP; Abraham DJ; Stratton RJ
J Invest Dermatol; 2010 Sep; 130(9):2191-200. PubMed ID: 20445556
[TBL] [Abstract][Full Text] [Related]
20. Adenoviral CCN3/NOV gene transfer fails to mitigate liver fibrosis in an experimental bile duct ligation model because of hepatocyte apoptosis.
Borkham-Kamphorst E; Huss S; Van de Leur E; Haas U; Weiskirchen R
Liver Int; 2012 Oct; 32(9):1342-53. PubMed ID: 22698069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
